|
Malaria is a major killer disease in Africa, and a primary cause of death and poverty. Approximately 90% of the 1.5 million deaths attributed to malaria each year occur in sub-saharan Africa. It is estimated that malaria costs Africa 12 billion US dollars annually in lost GDP. The malaria parasite is immune to the anti-malarial drugs currently used in most African health systems.
|
Malaria
Malaria Screening Project
iThemba Pharmaceuticals has screened two screening collections against malaria.
More than 160 compounds have been identified which are potent, novel, non-toxic anti-malarial compounds. Optimisation has begun on these compounds and partners are being sought to progress their development potential.